ABVC BioPharma, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $-3.1M | $-3.1M | — | $22.3K |
| FY2020 | $-4.6M | $-4.6M | — | $4.1M |
| FY2021 | $-7.6M | $-7.6M | $17.5K | $5.3M |
| FY2022 | $-7.4M | $-7.5M | $119.7K | $7.0M |
| FY2023 | $-4.2M | $-4.2M | $21.2K | $185.9K |